• Guideline Summary
  • NGC:010259
  • 2010 May (revised 2013 Feb)

Management of in-transit disease of the limbs.

  • Guideline Summary
  • NGC:010266
  • 2011 Feb (revised 2013 Feb)

Referral and follow-up surveillance of cutaneous melanoma.

Management of hepatitis C. A national clinical guideline.

  • Guideline Summary
  • NGC:010377
  • 2014 Feb

Adjuvant interferon for malignant melanoma.

British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013.

  • Guideline Summary
  • NGC:009271
  • 2012 Jun

KDIGO clinical practice guideline for glomerulonephritis.

  • Guideline Summary
  • NGC:010331
  • 2014 Feb

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and PEG interferon-α–based regimens.

  • Guideline Summary
  • NGC:010418
  • 2013 Oct

Recommendations for drug therapies for relapsing-remitting multiple sclerosis.

  • Guideline Summary
  • NGC:009076
  • 2012 Apr

Telaprevir for the treatment of genotype 1 chronic hepatitis C.

  • Guideline Summary
  • NGC:009075
  • 2012 Apr

Fingolimod for the treatment of highly active relapsing-remitting multiple sclerosis.

  • Guideline Summary
  • NGC:010260
  • 2010 May (revised 2013 Feb)

Management of resectable stage IV primary cutaneous melanoma without nodal disease.

Tuberculosis.

  • Guideline Summary
  • NGC:009937
  • 2004 Mar 16 (revised 2013 Sep 3)

Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement.

  • Guideline Summary
  • NGC:010505
  • 2004 Mar (revised 2014 Aug)

Guidelines of care for the management of atopic dermatitis. Section 3. Management and treatment with phototherapy and systemic agents.

  • Guideline Summary
  • NGC:010729
  • 2015 Apr

Peyronie's disease: AUA guideline.

  • Guideline Summary
  • NGC:010250
  • 2011 Jan (revised 2013 Oct)

Nonmuscle invasive bladder cancer.

  • Guideline Summary
  • NGC:010903
  • 2016 Jan

AASLD guidelines for treatment of chronic hepatitis B.

  • Guideline Summary
  • NGC:011067
  • 2016 Sep 6

Screening for latent tuberculosis infection in adults: U.S. Preventive Services Task Force recommendation statement.